Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom
    Guideline Concordant Care and New Data for Patients with MIBC through la/mUC
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom
    Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophilia
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom
    Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease Registry
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Germany
    Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia Infections
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Advancing Multidisciplinary Care in Hemophilia
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Acute Lymphoblastic Leukemia Peer-to-Peer Education & Support
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Understanding healthcare disparities in Atopic Dermatitis and Alopecia Areata patients
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology All
    ADVANCE: Global Awards for Advancing Chronic Pain Research
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Enhancing the Understanding of Health Maintenance in the Management of IBD
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Outpatient Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Turkmenistan, Ukraine, United Kingdom, Uzbekistan
    Emerging Therapies in Alopecia Areata for Dermatologists - United States
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    2021/2022 Global NASH ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Virtual Programs for Rheumatology Education
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis (Global (excluding the US)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    2021/2022 Global Obesity ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All